136 related articles for article (PubMed ID: 38317360)
1. [Expert consensus on the standardized procedure of selective internal radiation therapy with Yttrium-90 microspheres for liver malignancies (2024 edition)].
;
Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):486-498. PubMed ID: 38317360
[TBL] [Abstract][Full Text] [Related]
2. [Chinese expert consensus on selective internal radiation therapy with yttrium-90 for primary and metastatic hepatocellular carcinoma].
;
Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):648-658. PubMed ID: 34371535
[TBL] [Abstract][Full Text] [Related]
3. Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia.
Liu DM; Leung TW; Chow PK; Ng DC; Lee RC; Kim YH; Mao Y; Cheng YF; Teng GJ; Lau WY
Int J Surg; 2022 Jun; 102():106094. PubMed ID: 35662438
[TBL] [Abstract][Full Text] [Related]
4. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.
Levillain H; Bagni O; Deroose CM; Dieudonné A; Gnesin S; Grosser OS; Kappadath SC; Kennedy A; Kokabi N; Liu DM; Madoff DC; Mahvash A; Martinez de la Cuesta A; Ng DCE; Paprottka PM; Pettinato C; Rodríguez-Fraile M; Salem R; Sangro B; Strigari L; Sze DY; de Wit van der Veen BJ; Flamen P
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1570-1584. PubMed ID: 33433699
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
6. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
8. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
Konda A; Savin MA; Cappell MS; Duffy MC
Gastrointest Endosc; 2009 Sep; 70(3):561-7. PubMed ID: 19577743
[TBL] [Abstract][Full Text] [Related]
9. Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.
Ricke J; Klümpen HJ; Amthauer H; Bargellini I; Bartenstein P; de Toni EN; Gasbarrini A; Pech M; Peck-Radosavljevic M; Popovič P; Rosmorduc O; Schott E; Seidensticker M; Verslype C; Sangro B; Malfertheiner P
J Hepatol; 2019 Dec; 71(6):1164-1174. PubMed ID: 31421157
[TBL] [Abstract][Full Text] [Related]
10. Characterization of
Balagopal A; Kappadath SC
Med Phys; 2018 Feb; 45(2):875-883. PubMed ID: 29172243
[TBL] [Abstract][Full Text] [Related]
11. Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres.
Badiyan S; Bhooshan N; Chuong MD; Sharma N; Akhter N; Etezadi V; Hausner P; Kudryasheva S; Kaiser A; Becker S; Guerrero M; Yi BY
Nucl Med Commun; 2018 Oct; 39(10):915-920. PubMed ID: 30124600
[TBL] [Abstract][Full Text] [Related]
12. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.
Pardo F; Sangro B; Lee RC; Manas D; Jeyarajah R; Donckier V; Maleux G; Pinna AD; Bester L; Morris DL; Iannitti D; Chow PK; Stubbs R; Gow PJ; Masi G; Fisher KT; Lau WY; Kouladouros K; Katsanos G; Ercolani G; Rotellar F; Bilbao JI; Schoen M
Ann Surg Oncol; 2017 Sep; 24(9):2465-2473. PubMed ID: 28653161
[TBL] [Abstract][Full Text] [Related]
13. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
[TBL] [Abstract][Full Text] [Related]
14. Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review.
Baltatzis M; Siriwardena AK
Dig Surg; 2019; 36(4):273-280. PubMed ID: 29886488
[TBL] [Abstract][Full Text] [Related]
15. Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer.
Wang SC; Bester L; Burnes JP; Clouston JE; Hugh TJ; Little AF; Padbury RT; Price D
J Med Imaging Radiat Oncol; 2010 Jun; 54(3):178-87. PubMed ID: 20598004
[TBL] [Abstract][Full Text] [Related]
16.
Tabotta F; Gnesin S; Dunet V; Ponti A; Digklia A; Boughdad S; Schaefer N; Prior JO; Villard N; Tsoumakidou G; Denys A; Duran R
Sci Rep; 2023 Aug; 13(1):13118. PubMed ID: 37573346
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK.
Pennington B; Akehurst R; Wasan H; Sangro B; Kennedy AS; Sennfält K; Bester L
J Med Econ; 2015; 18(10):797-804. PubMed ID: 25941769
[TBL] [Abstract][Full Text] [Related]
19. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.
Kennedy A; Brown DB; Feilchenfeldt J; Marshall J; Wasan H; Fakih M; Gibbs P; Knuth A; Sangro B; Soulen MC; Pittari G; Sharma RA
J Gastrointest Oncol; 2017 Dec; 8(6):1079-1099. PubMed ID: 29299370
[TBL] [Abstract][Full Text] [Related]
20. A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK.
Pollock RF; Colaone F; Guardiola L; Shergill S; Brennan VK
J Med Econ; 2020 Jun; 23(6):593-602. PubMed ID: 32067534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
